Outcomes of modern antiretroviral therapy in obese individuals living with HIV

por Zino, L, Stalenhoef, J, Colbers, A, Burger, D M
Publicado 2022

More gastro-intestinal adverse events in non-ICU hospitalised COVID-19 patients treated with chloroquine versus hydroxychloroquine

por Verheijen, S., van Luin, M., Brüggemann, R.J., de Mast, Q., Hassing, R.J., Burger, D.M.
Publicado 2021

Indinavir/Low-dose Ritonavir Containing HAART in HIV-1 Infected Children has Potent Antiretroviral Activity, but is Associated with Side Effects and Frequent Discontinuation of Tre...

por Fraaij, P. L. A., Verweel, G., van Rossum, A. M. C., Hartwig, N. G., Burger, D. M., de Groot, R.
Publicado 2007

A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancer

por Desar, I M E, Timmer-Bonte, J N H, Burger, D M, van der Graaf, W T A, van Herpen, C M L
Publicado 2010

Prevalence of potential drug–drug interactions in cancer patients treated with oral anticancer drugs

por van Leeuwen, R W F, Brundel, D H S, Neef, C, van Gelder, T, Mathijssen, R H J, Burger, D M, Jansman, F G A
Publicado 2013

Drug–Drug Interactions Between Direct-Acting Antivirals and Psychoactive Medications

por Smolders, E. J., de Kanter, C. T. M. M., de Knegt, R. J., van der Valk, M., Drenth, J. P. H., Burger, D. M.
Publicado 2016

The effect of dipyridamole on the pharmacokinetics of metformin: a randomized crossover study in healthy volunteers

por El Messaoudi, S., Russel, F. G., Colbers, A., Bandell, C. C. J. G., van den Broek, P. H. H., Burger, D. M., Rongen, G. A., Riksen, N. P.
Publicado 2016

Prediction of Maternal and Fetal Doravirine Exposure by Integrating Physiologically Based Pharmacokinetic Modeling and Human Placenta Perfusion Experiments

por Bukkems, V. E., van Hove, H., Roelofsen, D., Freriksen, J. J. M., van Ewijk-Beneken Kolmer, E. W. J., Burger, D. M., van Drongelen, J., Svensson, E. M., Greupink, R., Colbers, A.
Publicado 2022

Off-label, but on target: the evidence needed to implement alternative dosing regimens of anticancer drugs

por Overbeek, J.K., Heine, R. ter, Verheul, H.M.W., Chatelut, E., Rudek, M.A., Gurney, H., Plummer, R., Gilbert, D.C., Buclin, T., Burger, D.M., Bloemendal, H.J., van Erp, N.P.
Publicado 2023

Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals

por Brüggemann, R.J., Moes, D.J.A.R., van Rhee, K.P., van 't Veer, N.E., Koch, B.C.P., van Rossum, M., Windsant - van den Tweel, A. Vermeulen, Reijers, M.H.E., van Kimmenade, R.R.J., Rahamat-Langedoen, J.C., Rettig, T.C.D., van Raalte, R., van Paassen, J., Polderman, F.N., van der Linden, P.D., Frenzel, T., de Mast, Q., Burger, D.M., Schouten, J., van de Veerdonk, F.L., Pickkers, P., ter Heine, R.
Publicado 2021